1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Nov 14, 2024.
The trade is 30.0% of the 15,008 shares held after it.
1 other insider sold within 30 days.
119 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Claims Officer Ozuna Christina M. sold about $179.5K of EIG on Mar 10, 2026; 1 other insider sold within 30 days and 119 funds added in the latest 13F quarter.
2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Feb 28, 2025.
The trade is 57.4% of the 8,704 shares held after it.
1 other insider sold within 30 days.
119 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Actuarial and UW Officer Smith Ann Marie sold about $196.4K of EIG on Mar 9, 2026, the largest insider sale at the company on our record; 1 other insider sold within 30 days and 119 funds added in the latest 13F quarter.
2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on Aug 5, 2025.
-14.2% median (-14.2% mean) 90-day return after 2 previous buys.
The trade is 30.8% of the 17,830 shares held after it.
No other insider bought within 30 days.
119 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP, Chief Financial Officer Pedraja Michael bought about $204.0K of EIG on Nov 4, 2025, the largest insider purchase at the company since 2023; 119 funds added in the latest 13F quarter.
1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on May 6, 2025.
The trade is 40.6% of the 12,330 shares held after it.
No other insider bought within 30 days.
119 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP, Chief Financial Officer Pedraja Michael bought about $200.2K of EIG on Aug 5, 2025, the largest insider purchase at the company since 2023; 119 funds added in the latest 13F quarter.
17 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$837.6M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM EIG
FY Dec 2025
$858.7M
FY Dec 2024
$880.7M
FY Dec 2023
$850.9M
FY Dec 2022
$713.5M
FY Dec 2021
$703.1M
Jun 2026
$220.2M
Mar 2026
$207.6M
Dec 2025
$170.5M
Sep 2025
$239.3M
Jun 2025
$246.3M
Mar 2025
$202.6M
Dec 2024
$216.6M
Sep 2024
$224.0M
At each fiscal year end
Single quarter
Net margin, TTM
+0.9%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM EIG
FY Dec 2025
+1.3%
FY Dec 2024
+13.5%
FY Dec 2023
+13.9%
FY Dec 2022
+6.8%
FY Dec 2021
+17.0%
Jun 2026
+13.2%
Mar 2026
+4.9%
Dec 2025
-13.7%
Sep 2025
-3.5%
Jun 2025
+12.1%
Mar 2025
+6.3%
Dec 2024
+13.1%
Sep 2024
+13.5%
At each fiscal year end
Single quarter
Free cash flow, TTM
$21.8M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM EIG
FY Dec 2025
$44.6M
FY Dec 2024
$76.3M
FY Dec 2023
$49.4M
FY Dec 2022
$99.7M
FY Dec 2021
$10.5M
Jun 2026
-$10.9M
Mar 2026
$1.3M
Dec 2025
$2.6M
Sep 2025
$28.8M
Jun 2025
-$900.0K
Mar 2025
$14.1M
Dec 2024
$16.2M
Sep 2024
$50.1M
At each fiscal year end
Single quarter
Debt to equity
0.15x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Debt to equity EIG
FY Dec 2025
0.04x
FY Dec 2024
0.00x
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
0.15x
Mar 2026
0.14x
Dec 2025
0.04x
Sep 2025
0.00x
Jun 2025
0.00x
Mar 2025
0.00x
Dec 2024
0.00x
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.18x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Cash flow to debt EIG
FY Dec 2025
1.28x
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
0.18x
Mar 2026
0.26x
Dec 2025
1.28x
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+0.8%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity EIG
FY Dec 2025
+1.1%
FY Dec 2024
+11.4%
FY Dec 2023
+12.1%
FY Dec 2022
+4.5%
FY Dec 2021
+9.8%
Jun 2026
+0.8%
Mar 2026
+0.8%
Dec 2025
+1.1%
Sep 2025
+5.9%
Jun 2025
+9.6%
Mar 2025
+9.8%
Dec 2024
+11.4%
Sep 2024
+13.5%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+0.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets EIG
FY Dec 2025
+0.3%
FY Dec 2024
+3.3%
FY Dec 2023
+3.3%
FY Dec 2022
+1.3%
FY Dec 2021
+3.1%
Jun 2026
+0.2%
Mar 2026
+0.2%
Dec 2025
+0.3%
Sep 2025
+1.7%
Jun 2025
+2.9%
Mar 2025
+2.9%
Dec 2024
+3.3%
Sep 2024
+3.8%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital EIG
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed EIG
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
65.92x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing EIG
FY Dec 2025
100.40x
FY Dec 2024
10.88x
FY Dec 2023
8.87x
FY Dec 2022
24.51x
FY Dec 2021
9.90x
Jun 2026
63.90x
Mar 2026
95.67x
Dec 2025
100.40x
Sep 2025
16.79x
Jun 2025
11.51x
Mar 2025
12.29x
Dec 2024
10.88x
Sep 2024
9.03x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$947.1M
market value at close 2026-10-23 on 2026-07-28 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
Enterprise value EIG
FY Dec 2025
$845.6M
FY Dec 2024
$1.2B
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
$932.6M
Mar 2026
$773.4M
Dec 2025
$845.6M
Sep 2025
$832.0M
Jun 2025
$1.1B
Mar 2025
$1.1B
Dec 2024
$1.2B
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+2.3%
TTM free cash flow over market value at close 2026-10-23
FCF yield EIG
FY Dec 2025
+4.6%
FY Dec 2024
+6.0%
FY Dec 2023
+4.9%
FY Dec 2022
+8.5%
FY Dec 2021
+0.9%
Jun 2026
+2.4%
Mar 2026
+4.0%
Dec 2025
+4.6%
Sep 2025
+5.8%
Jun 2025
+7.0%
Mar 2025
+7.4%
Dec 2024
+6.0%
Sep 2024
+7.5%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -81%, PEG needs growth
PEG, trailing EIG
FY Dec 2025
n/a
FY Dec 2024
1.79x
FY Dec 2023
0.06x
FY Dec 2022
n/a
FY Dec 2021
3.66x
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
1.79x
Sep 2024
0.44x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
EIG ranks highest on risk and compliance (63rd percentile) and financial health (50th), and lowest on growth (11th), among Insurance peers.
Profitability
15
Inputs
Return on equity+0.8% · 13 pct, sector of 116
Return on assets+0.2% · 17 pct, sector of 122
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Financial health
50
Inputs
Debt to equity0.15x · 80 pct, sector of 104
Cash flow to debt0.18x · 21 pct, sector of 97
Growth
11
Inputs
Revenue growth, YoY-2.5% · 11 pct, sector of 134
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
41
Inputs
Funds adding, latest quarter119 · 41 pct, sector of 108
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
63
Inputs
Short interest, % of float+5.3% · 30 pct, sector of 138
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+2.4% · 95 pct, sector of 110
2 not measured: Insider conviction, US patents
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
EIG filings, in plain words
Have members of Congress traded EIG?
Yes, but not in the year to 2026-10-27; the latest on record is a sale by Lisa McClain dated 2025-07-10.
Read the full summary
Members of Congress have disclosed trades in EIG, none in the last year; the latest on record is a sale by Lisa McClain dated 2025-07-10. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.